54998-00-4

Basic information

• Product Name: 4-(3-Amino-4-nitrophenyl)morpholine
• Synonyms: 5-MORPHOLIN-4-YL-2-NITRO-ANILINE;5-MORPHOLIN-4-YL-2-NITRO-PHENYLAMINE;5-MORPHOLINO-2-NITROANILINE;BUTTPARK 17\04-70;4-(3-Amino-4-nitrophenyl)morpholine;5-morpholino-2-nitrobenzenamine
• CAS NO: 54998-00-4
• Molecular Formula: C₁₀H₁₃N₃O₃
• Molecular Weight: 223.23
• Mol File: 54998-00-4.mol
• Article Data: 25

Chemical Properties

• Melting Point: 182-185°C
• Boiling Point: 469.7°C at 760 mmHg
• Flash Point: 237.9°C
• Appearance: /
• Density: 1.337g/cm³
• Vapor Pressure: 5.38E-09mmHg at 25°C
• Refractive Index: 1.623
• Storage Temp.: 2-8°C
• PKA: 0.86±0.40(Predicted)
• CAS DataBase Reference: 4-(3-Amino-4-nitrophenyl)morpholine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3-Amino-4-nitrophenyl)morpholine(54998-00-4)
• EPA Substance Registry System: 4-(3-Amino-4-nitrophenyl)morpholine(54998-00-4)

Safety Data

• Statements: 20/21/22-36/37/38
• Safety Statements: 26-36/37/39
• HazardClass: IRRITANT
• Hazardous Substances Data: 54998-00-4(Hazardous Substances Data)

Usage

General Description

4-(3-Amino-4-nitrophenyl)morpholine is a chemical compound with the molecular formula C10H13N3O3. It is an aromatic amine derivative containing a morpholine ring, and it has both amino and nitro substituents attached to the phenyl ring. 4-(3-Amino-4-nitrophenyl)morpholine is used in the synthesis of pharmaceuticals, specifically in the development of anti-inflammatory and anti-cancer drugs. It has also been studied for its potential antiparasitic and antimicrobial properties. Additionally, 4-(3-Amino-4-nitrophenyl)morpholine has been investigated for its role in antioxidant and neuroprotective applications. Overall, this chemical has potential uses in the pharmaceutical and medical industries due to its diverse range of properties and potential therapeutic effects.

InChI:InChI=1/C10H13N3O3/c11-9-7-8(1-2-10(9)13(14)15)12-3-5-16-6-4-12/h1-2,7H,3-6,11H2

Upstream product

• 64-17-5 ethanol 
• 555-16-8 4-nitrobenzaldehdye 
• 5228-61-5 5-bromo-2-nitroaniline 
• 110-91-8 morpholine 
• 1635-61-6 5-chloro-2-nitroaniline 
• 68-12-2 N,N-dimethyl-formamide 

Downstream Products

• 119421-28-2 4-morpholinobenzene-1,2-diamine 
• 897446-65-0 2-cyclohexyl-N-(5-morpholin-4-yl-2-nitrophenyl)-2-phenylacetamide 
• 949570-75-6 methyl 4-chloro-2-(5-morpholino-2-nitrophenylamino)benzoate 
• 1187383-65-8 (2S)-N-{4-(5-[2-[(4-(benzyloxy)phenyl)-6-morpholino]benzimidazol-1-yl]pentyl)oxy-5-methoxy-2-nitrobenzoyl}pyrrolidine-2-carboxaldehyde diethyl thioacetal 
• 1187383-66-9 (2S)-N-{4-(5-[2-[(4-(benzyloxy)phenyl)-6-morpholino]benzimidazol-1-yl]pentyl)oxy-5-methoxy-2-aminobenzoyl}pyrrolidine-2-carboxaldehyde diethyl thioacetal 
• 1187383-55-6 7-methoxy-8-{5-[2-[(4-(benzyloxy)phenyl)-6-morpholino]benzimidazol-1-yl]pentyl}oxy-(11aS)-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 
• 1187383-72-7 4-{2-[4-(benzyloxy)phenyl]benzimidazol-6-yl}morpholine 
• 1227867-14-2 6-[(2-amino-5-morpholinophenyl)amino]-4-[(3,5-difluorobenzyl)amino]pyridine-3-carboxyamide 
• 402948-33-8 ethyl 2-(5-morpholin-4-ylbenzimidazol-2-yl)acetate 
• 111861-06-4 5⁽⁶⁾-Morpholino-2-(4-nitrophenyl)benzimidazole 

Relevant articles and documents

Benzimidazole compound, preparation method thereof and application of the benzimidazole compound in preparation of ferroptosis inhibitor

The invention discloses a benzimidazole compound, a preparation method thereof and application of the benzimidazole compound in preparation of a ferroptosis inhibitor. The benzimidazole compound has a structure as shown in a formula (I) or a formula (II)

Pyrazole spleen tyrosine kinase inhibitor as well as preparation method and application thereof

The invention discloses a pyrazole spleen tyrosine kinase inhibitor, a preparation method thereof, a pharmaceutical composition containing the same, and application of the pyrazole spleen tyrosine kinase inhibitor and the pharmaceutical composition in the preparation of drugs for treating Syk-mediated diseases including cancers, inflammatory diseases and the like.

Heterocycle type derivative and preparing method and pharmaceutical application thereof

The invention relates to a novel heterocycle type derivative, a preparing method thereof, a medicine composition containing the derivative and application of the heterocycle type derivative as therapeutic agent, particularly an FGFR4 inhibitor. The preferable compound has a good inhibiting effect on FGFR4.